PubMed

Using conjoint analysis to estimate healthy-year equivalents for acute conditions: an application to vasomotor symptoms.

Johnson FR, Hauber AB, Ozdemir S.

Value Health. 2009 Jan;12(1):146-52.PMID: 19911445 [PubMed - in process]Related articles

Using the Incremental Net Benefit Framework for Quantitative Benefit-Risk Analysis in Regulatory Decision-Making-A Case Study of Alosetron in Irritable Bowel Syndrome.

Lynd LD, Najafzadeh M, Colley L, Byrne MF, Willan AR, Sculpher MJ, Johnson FR, Hauber AB.

Value Health. 2009 Sep 10. [Epub ahead of print]PMID: 19744297 [PubMed - as supplied by publisher]Related articles

Healthy-years equivalent: wounded but not yet dead.

Hauber AB.

Expert Rev Pharmacoecon Outcomes Res. 2009 Jun;9(3):265-9. Review.PMID: 19527099 [PubMed - indexed for MEDLINE]Related articles

Hypothetical bias, cheap talk, and stated willingness to pay for health care.

Ozdemir S, Johnson FR, Hauber AB.

J Health Econ. 2009 Jul;28(4):894-901. Epub 2009 Apr 18.PMID: 19464743 [PubMed - in process]Related articles

Quantifying asthma patient preferences for onset of effect of combination inhaled corticosteroids and long-acting beta2-agonist maintenance medications.

Hauber AB, Mohamed AF, Johnson FR, Meddis D, Wagner S, O'Dowd L.

Allergy Asthma Proc. 2009 Mar-Apr;30(2):139-47.PMID: 19463204 [PubMed - indexed for MEDLINE]Related articles

Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose-lowering agents.

Hauber AB, Mohamed AF, Johnson FR, Falvey H.

Diabet Med. 2009 Apr;26(4):416-24.PMID: 19388973 [PubMed - indexed for MEDLINE]Related articles

Who pays attention in stated-choice surveys?

Ozdemir S, Mohamed AF, Johnson FR, Hauber AB.

Health Econ. 2009 Mar 6. [Epub ahead of print]PMID: 19267358 [PubMed - as supplied by publisher]Related articles

Benefits, risk, and uncertainty: preferences of antiretroviral-naïve African Americans for HIV treatments.

Hauber AB, Mohamed AF, Watson ME, Johnson FR, Hernandez JE.

AIDS Patient Care STDS. 2009 Jan;23(1):29-34.PMID: 19113949 [PubMed - indexed for MEDLINE]Related articles

Evaluation of the relative importance of chemotherapeutic and antiemetic efficacy in various oncologic settings.

Ettinger DS, Grunberg SM, Hauber AB, Mohamed AF.

Support Care Cancer. 2009 Apr;17(4):405-11. Epub 2008 Sep 2.PMID: 18762991 [PubMed - indexed for MEDLINE]Related articles

Older Americans' risk-benefit preferences for modifying the course of Alzheimer disease.

Hauber AB, Johnson FR, Fillit H, Mohamed AF, Leibman C, Arrighi HM, Grundman M, Townsend RJ.

Alzheimer Dis Assoc Disord. 2009 Jan-Mar;23(1):23-32.PMID: 18725862 [PubMed - indexed for MEDLINE]Related articles

Factors that affect adherence to bipolar disorder treatments: a stated-preference approach.

Johnson FR, Ozdemir S, Manjunath R, Hauber AB, Burch SP, Thompson TR.

Med Care. 2007 Jun;45(6):545-52.PMID: 17515782 [PubMed - indexed for MEDLINE]Related articles

Are chemotherapy patients' HRQoL importance weights consistent with linear scoring rules? A stated-choice approach.

Johnson FR, Hauber AB, Osoba D, Hsu MA, Coombs J, Copley-Merriman C.

Qual Life Res. 2006 Mar;15(2):285-98.PMID: 16468083 [PubMed - indexed for MEDLINE]Related articles

Risking health to avoid injections: preferences of Canadians with type 2 diabetes.

Hauber AB, Johnson FR, Sauriol L, Lescrauwaet B.

Diabetes Care. 2005 Sep;28(9):2243-5. No abstract available. PMID: 16123499 [PubMed - indexed for MEDLINE]Related articlesFree article

The relationship between health perception and utility in heart failure patients in a clinical trial: results from an OVERTURE substudy.

Havranek EP, Simon TA, L'Italien G, Smitten A, Hauber AB, Chen R, Lapuerta P.

J Card Fail. 2004 Aug;10(4):339-43.PMID: 15309702 [PubMed - indexed for MEDLINE]Related articles

Potential savings in the cost of caring for Alzheimer's disease. Treatment with rivastigmine.

Hauber AB, Gnanasakthy A, Snyder EH, Bala MV, Richter A, Mauskopf JA.

Pharmacoeconomics. 2000 Apr;17(4):351-60. Review.PMID: 10947490 [PubMed - indexed for MEDLINE]Related articles

Savings in the cost of caring for patients with Alzheimer's disease in Canada: an analysis of treatment with rivastigmine.

Hauber AB, Gnanasakthy A, Mauskopf JA.

Clin Ther. 2000 Apr;22(4):439-51.PMID: 10823365 [PubMed - indexed for MEDLINE]Related articles